FDA approves drug for treatment of rare leukemia type
from The Wall Street Journal
Talon Therapeutics's leukemia treatment has been approved by the Food & Drug Administration to treat adults with a rare type of the cancer. The FDA said it had approved Marqibo, a vincristine sulfate liposome injection, to treat adults with Philadelphia chromosome-negative acute lymphoblastic leukemia.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063